Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene
Abstract Background Hereditary angioedema (HAE) in patients with normal C1 inhibitor (C1-INH) and the c.988A > G (p.Lys330Glu; p.K330E) variant in the plasminogen gene (HAE-PLG) is associated with skin swellings, abdominal pain attacks, and the risk of asphyxiation due to upper airway obstruction...
Main Authors: | Konrad Bork, Karin Wulff, Guenther Witzke, Thomas Machnig, Jochen Hardt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-1334-8 |
Similar Items
-
Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
by: Lundy McKibbin, et al.
Published: (2019-11-01) -
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
by: Stefan Hintze, et al.
Published: (2023-01-01) -
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
by: Hilary J. Longhurst, et al.
Published: (2018-08-01) -
Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing
by: Adil Adatia, MD, et al.
Published: (2023-05-01) -
Diagnosis and screening of patients with hereditary angioedema in primary care
by: Henao MP, et al.
Published: (2016-05-01)